MedicaidPrior AuthMedium impact
Opioid Utilization Program - Concurrent Use of Opioids/Benzodiazepines and Buprenorphine (Revised)
Humana·LA · Pain Management, Psychiatry, Family Medicine +2 more·Medicaid
Effective date
Oct 1, 2025
We identified it
Jun 24, 2026
Summary
Humana Medicaid Louisiana has updated their opioid utilization program policy for concurrent use of opioids, benzodiazepines, and buprenorphine. The policy establishes strict override rules: no overrides for prescriptions from different prescribers when buprenorphine is involved, and same-prescriber confirmation required for concurrent therapy approvals.
Action Required
Before October 1, 2025: Providers prescribing opioids, benzodiazepines, or buprenorphine for Louisiana Medicaid patients must establish procedures to confirm concurrent therapy requests. Billing team should alert providers that override approvals require prescriber confirmation for same-provider concurrent prescriptions, and no overrides will be authorized for different prescribers when buprenorphine is involved. Update prior authorization workflow to account for these restrictions.